We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Carlsson, A. (1970) Biochemical implications of Dopa-induced actions on the central nervous system, with particular reference to abnormal movements. In L-Dopa and Parkinsonism (eds Barbeau, & McDowell, ). Philadelphia: F. A. Davis.Google Scholar
Crane, G. E. (1972) Pseudoparkinsonism and tardive dyskinesia. Archives of Neurology, 27, 426–430.Google Scholar
Garcia Ribera, C., Ruiz, I., Guillamat, R., Hortal, M., Udina, G., Alvarez, E., Casas, M.A therapeutic alternative in tardive dyskinesia. Proceedings of the National Meeting of Biological PsychiatryOviedoAsturias, 17–19 November1985(in press).Google Scholar
Goetz, C. G., Weiner, W. J., Nausœda, P. A., Klawans, H. L. (1982) Tardive dyskinesia: pharmacology and clinical implications. Clinical Neuropharmacology, 5, 3–22.Google Scholar
eLetters
No eLetters have been published for this article.